Drugs target to EZH2

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
TAZEMETOSTATSmall moleculenoneHistone-lysine N-methyltransferase EZH2 inhibitor4['Recruiting', 'Completed', 'Recruiting', 'Completed', 'Not yet recruiting', 'Not yet recruiting', 'Completed', 'Recruiting', 'Not yet recruiting', 'Terminated', '-', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Recruiting', '-', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting', 'Not yet recruiting', '-', 'Recruiting']['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'DailyMed', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials']
TAZEMETOSTAT HYDROBROMIDESmall moleculenoneHistone-lysine N-methyltransferase EZH2 inhibitor4['-', 'Recruiting', 'Not yet recruiting', '-']['DailyMed', 'ClinicalTrials', 'ClinicalTrials', 'FDA']
GSK2816126Small moleculenoneHistone-lysine N-methyltransferase EZH2 inhibitor1['Terminated']['ClinicalTrials']